radiotherapy
Showing 26 - 50 of >10,000
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Simple Blood Test to Reduce Unnecessary Adverse Effects From
Not yet recruiting
- Pathological Response Rate, Circulating Tumour DNA
- MeD-seq
- (no location specified)
Sep 6, 2023
Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)
Not yet recruiting
- Locally-advanced Rectal Cancer
- mFOLFIRINOX
- +6 more
-
Lyon, Rhöne, France
- +1 more
Jun 12, 2023
Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)
Recruiting
- Brain Metastases
- +2 more
- brain radiotherapy
- Almonertinib
-
Guangdong, Guangzhou, ChinaSun-Yat-Sen university
Mar 13, 2023
Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)
Recruiting
- Pancreatic Carcinoma
- carbon ion radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Apr 25, 2023
Lung Cancer, Radiotherapy, Stereotactic Body Radiotherapy Trial in Peking (SBRT)
Active, not recruiting
- Lung Cancer
- +3 more
- SBRT
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Mar 26, 2023
Early Metastasis in Cervical Cancer Patients After Radiotherapy
Not yet recruiting
- Cervical Cancer
- +4 more
- external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Oct 21, 2023
Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)
Recruiting
- Extensive Small Cell Lung Cancer
- Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023
Radiotherapy Side Effect, Mucositis Trial in Bani Suwayf (MEBO ointment, Symptomatic treatment only)
Active, not recruiting
- Radiotherapy Side Effect
- Mucositis
- MEBO ointment
- Symptomatic treatment only
-
Banī Suwayf, EgyptAsmaa Abdelfattah Elsayed
Nov 11, 2023
Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)
Not yet recruiting
- Recurrent Glioblastoma
- fractionated radiotherapy
- cadonilimab
- (no location specified)
Feb 20, 2023
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy
Recruiting
- Urothelial Carcinoma
- Radiotherapy
- +2 more
-
Beijing, China
- +2 more
Nov 2, 2023
Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)
Recruiting
- Colorectal Liver Metastases
- Radiation: High- and Low-dose radiotherapy
- PD-1 Inhibitors
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Sep 13, 2023
Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)
Recruiting
- Pancreatic Cancer
- LDR
- +2 more
-
Modena, MO, ItalyAzienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022
Brain Tumor, Primary, Brain Tumor - Metastatic Trial in Erlangen (brain radiotherapy)
Not yet recruiting
- Brain Tumor, Primary
- Brain Tumor - Metastatic
- brain radiotherapy
-
Erlangen, GermanyErlangen, Universitätsklinikum Strahlenklinik
Oct 24, 2023
Rectal Cancer Trial in Bergen (On-couch adaptive radiotherapy)
Not yet recruiting
- Rectal Cancer
- On-couch adaptive radiotherapy
-
Bergen, NorwayHaukeland University Hospital
May 22, 2023
Lung Tumor Malignant Trial in Milano (SBRT, Surgery)
Not yet recruiting
- Lung Neoplasm Malignant
- SBRT
- Surgery
-
Milano, MI, ItalyIstituto Europeo di Oncologia IRCCS
Jul 26, 2023
Unresectable Solid Tumor, Metastatic Cancer Trial in Saint Louis (Proton GRID Radiotherapy)
Not yet recruiting
- Unresectable Solid Tumor
- Metastatic Cancer
- Proton GRID Radiotherapy
-
Saint Louis, MissouriWashington University School of Medicine
Apr 25, 2023
Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Atezolizumab
- +2 more
-
Taoyuan City, TaiwanChang Gung Memorial Hospital at Linkou
Nov 17, 2023
Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)
Not yet recruiting
- Advanced Non-Small Cell Squamous Lung Cancer
- +2 more
- CTV omitted or delineated
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 7, 2023
Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)
Recruiting
- Radiotherapy
- +3 more
- SBRT
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 2, 2023
HRQOL in Prostate Cancer Patients Treated With Radiotherapy
Recruiting
- Prostate Cancer
- radiotherapy
-
Rotterdam, Zuid-Holland, NetherlandsRadiotherapy, Erasmus MC Cancer Center
Dec 8, 2022
PROSTATE CANCER Trial in Petah Tikva (Two-fraction stereotactic radiotherapy, Five-fraction stereotactic radiotherapy)
Recruiting
- PROSTATE CANCER
- Two-fraction stereotactic radiotherapy
- Five-fraction stereotactic radiotherapy
-
Petah Tikva, IsraelDavidoff Cancer Center, Rabin Medical Center
Sep 7, 2023
Radiotherapy-Associated Atrial Fibrillation
Completed
- Atrial Fibrillation New Onset
- ECG
-
Fatih, Istanbul, TurkeyIstanbul Faculty of Medicine
Jun 29, 2023
Urothelial Carcinoma Trial (Disitamab Vedotin, radiotherapy)
Not yet recruiting
- Urothelial Carcinoma
- Disitamab Vedotin
- radiotherapy
- (no location specified)
Jun 20, 2023
Patient With Radiotherapy (Linac MRI), Mobile Cancerous Lesion Trial (With non-magnetic screen)
Not yet recruiting
- Patient With Radiotherapy (Linac MRI)
- Mobile Cancerous Lesion
- With non-magnetic screen
- (no location specified)
Mar 23, 2023